279 related articles for article (PubMed ID: 23754771)
1. Quality of case reports of adverse drug reactions with psychotropic drugs: a 25-year review.
Talat B; Mayers A; Baldwin DS
Hum Psychopharmacol; 2013 Sep; 28(5):413-20. PubMed ID: 23754771
[TBL] [Abstract][Full Text] [Related]
2. No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain.
D'Incau P; Lapeyre-Mestre M; Carvajal A; Donati M; Salado I; Rodriguez L; Sáinz M; Escudero A; Conforti A
Fundam Clin Pharmacol; 2014 Jun; 28(3):342-8. PubMed ID: 23617454
[TBL] [Abstract][Full Text] [Related]
3. Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs.
Sessa M; Rafaniello C; Sportiello L; Mascolo A; Scavone C; Maccariello A; Iannaccone T; Fabrazzo M; Berrino L; Rossi F; Capuano A
Expert Opin Drug Saf; 2016 Dec; 15(sup2):9-15. PubMed ID: 27875917
[TBL] [Abstract][Full Text] [Related]
4. The quality of published adverse drug event reports.
Kelly WN
Ann Pharmacother; 2003 Dec; 37(12):1774-8. PubMed ID: 14632590
[TBL] [Abstract][Full Text] [Related]
5. Adverse event assessment methods in published trials of psychotropic drugs: Poor reporting and neglect of emerging safety concerns.
Hughes S; Cohen D; Johnson R
Int J Risk Saf Med; 2016 Aug; 28(2):101-14. PubMed ID: 27567767
[TBL] [Abstract][Full Text] [Related]
6. How can we improve the assessment of safety in child and adolescent psychopharmacology?
Vitiello B; Riddle MA; Greenhill LL; March JS; Levine J; Schachar RJ; Abikoff H; Zito JM; McCracken JT; Walkup JT; Findling RL; Robinson J; Cooper TB; Davies M; Varipatis E; Labellarte MJ; Scahill L; Capasso L
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):634-41. PubMed ID: 12921470
[TBL] [Abstract][Full Text] [Related]
7. Adverse cutaneous reactions to psychotropic drugs.
MacMorran WS; Krahn LE
Psychosomatics; 1997; 38(5):413-22. PubMed ID: 9314710
[TBL] [Abstract][Full Text] [Related]
8. [Patient reporting of adverse drug reactions in Norway 2010-13].
Fjermeros K; Werner MC; Harg P; Samdal H; Slørdal L; Spigset O
Tidsskr Nor Laegeforen; 2015 Mar; 135(6):536-40. PubMed ID: 25806761
[TBL] [Abstract][Full Text] [Related]
9. The AMUP study for drug surveillance in psychiatry - a summary of inpatient data.
Grohmann R; Hippius H; Helmchen H; Rüther E; Schmidt LG
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S16-26. PubMed ID: 15052511
[TBL] [Abstract][Full Text] [Related]
10. [How to evaluate side effects in a clinical trial?].
Maurel M; Belzeaux R; Adida M; Azorin JM
Encephale; 2016 Dec; 42(6S):S30-S32. PubMed ID: 28236990
[TBL] [Abstract][Full Text] [Related]
11. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
12. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis.
Davidson TM; Smith WM
Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):673-6. PubMed ID: 20644061
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
[TBL] [Abstract][Full Text] [Related]
14. Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.
Aronson JK
Expert Rev Clin Pharmacol; 2015; 8(4):399-409. PubMed ID: 26018632
[TBL] [Abstract][Full Text] [Related]
15. Blood dyscrasias induced by psychotropic drugs.
Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517
[TBL] [Abstract][Full Text] [Related]
16. Causality assessment in pharmacovigilance: The French method and its successive updates.
Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
[TBL] [Abstract][Full Text] [Related]
17. Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan.
Kubota K; Okazaki M; Dobashi A; Yamamoto M; Hashiguchi M; Horie A; Inagaki A; Kikuchi T; Mochizuki M
Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1134-7. PubMed ID: 24092565
[No Abstract] [Full Text] [Related]
18. Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
Oosterhuis I; Taavola H; Tregunno PM; Mas P; Gama S; Newbould V; Caster O; Härmark L
Drug Saf; 2018 Oct; 41(10):969-978. PubMed ID: 29761281
[TBL] [Abstract][Full Text] [Related]
19. [French pharmacovigilance database system: examples of utilisation].
Moore N; Noblet C; Kreft-Jais C; Lagier G; Ollagnier M; Imbs JL
Therapie; 1995; 50(6):557-62. PubMed ID: 8745956
[TBL] [Abstract][Full Text] [Related]
20. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
Mey C; Hentschel H; Hippius M; Balogh A
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
